Eficacia y seguridad de la terapia con inhibidores de la PCSK9 en el tratamiento de las dislipidemias y riesgo cardiovascular
Dyslipidemia, defined as an alteration in blood lipid levels. In particular, cholesterol and triglycerides are a key risk factor for cardiovascular health. Protein convertase subtilisin/kexin type 9 (PCSK9) inhibitors are mechanisms used to treat diseases related to excess cholesterol in the blood....
Gardado en:
| Autor Principal: | |
|---|---|
| Formato: | bachelorThesis |
| Idioma: | spa |
| Publicado: |
2025
|
| Subjects: | |
| Acceso en liña: | https://dspace.uniandes.edu.ec/handle/123456789/19185 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|
Engadir etiqueta